Study Reveals a Hidden Partnership in the Infant Gut

A new study, published in Nature Communications, has detailed a previously unknown cooperative relationship between two types of bacteria in the gut of breastfed infants. The research analyzed stool samples from 41 healthy mother-infant pairs in the Netherlands using deep DNA sequencing.

A Cross-Feeding Cycle

The core finding describes a mutualistic cycle facilitated by components of breast milk.

Human Milk Oligosaccharides (HMOs) consumed by Bifidobacterium also support E. coli, a relationship not previously shown in breastfed infants.

• Step 1: Bifidobacterium, a bacterium considered a key component of a healthy infant gut, breaks down complex sugars (HMOs) found in breast milk.
• Step 2: E. coli then consumes the simpler sugars left behind by Bifidobacterium.
• Step 3: A byproduct of E. coli's metabolism, the amino acid cysteine, in turn serves as a nutrient source for Bifidobacterium.

This cross-feeding relationship is suggested to help maintain E. coli at low, stable levels while supporting a Bifidobacterium-rich gut ecosystem.

Significance and Bacterial Origins

The findings indicate E. coli may play a beneficial role in early gut microbiome and immune system development when present at low levels, rather than being solely harmful. This specific mutualistic co-existence in breastfed infants had not been detailed before.

The sequencing also provided insights into how these bacteria colonize the infant gut:

• Several Bifidobacterium strains were shared between mothers and their infants.
• E. coli strains were typically found to originate from outside the family but could persist within an infant over time.

Identifying the sources of these bacterial strains is noted as important for understanding infant exposure to beneficial gut bacteria.

Expert Commentary

Professor Lindsay Hall, the corresponding author, emphasized the importance of stable bacterial communities: "This mutualistic relationship may be required for stable bacterial co-existence, which is significant for healthy infant development."

Dr. David Seki, the first author, highlighted ongoing questions: "Fundamental gaps remain in understanding the ecology of E. coli and the factors determining its role as a commensal or pathogen."

Potential Future Applications

The insights from this research could inform future developments in infant nutrition and health, particularly for vulnerable groups:

• Informing new treatments or supplements for preterm infants.
• Aiding infants who do not have consistent access to breast milk.
• Considering methods to introduce beneficial bacterial strains to support typical gut microbiome development.